References
- Chal J and Pourquie O (2017) Making muscle: skeletal myogenesis in vivo and in vitro. Development 144, 2104-2122 https://doi.org/10.1242/dev.151035
- Asfour HA, Allouh MZ and Said RS (2018) Myogenic regulatory factors: The orchestrators of myogenesis after 30 years of discovery. Exp Biol Med (Maywood) 243, 118-128 https://doi.org/10.1177/1535370217749494
- Benarroch L, Bonne G, Rivier F and Hamroun D (2019) The 2020 version of the gene table of neuromuscular disorders (nuclear genome). Neuromuscul Disord 29, 980-1018 https://doi.org/10.1016/j.nmd.2019.10.010
- Akhmedov D and Berdeaux R (2013) The effects of obesity on skeletal muscle regeneration. Front Physiol 4, 371 https://doi.org/10.3389/fphys.2013.00371
- Chang YC, Liu HW, Chen YT, Chen YA, Chen YJ and Chang SJ (2018) Resveratrol protects muscle cells against palmitate-induced cellular senescence and insulin resistance through ameliorating autophagic flux. J Food Drug Anal 26, 1066-1074 https://doi.org/10.1016/j.jfda.2018.01.006
- Zhang G, Chen X, Lin L, Wen C and Rao S (2012) [Effects of fatty acids on proliferation and differentiation of myoblast]. Wei Sheng Yan Jiu 41, 883-888
- Saini A, Sharples AP, Al-Shanti N and Stewart CE (2017) Omega-3 fatty acid EPA improves regenerative capacity of mouse skeletal muscle cells exposed to saturated fat and inflammation. Biogerontology 18, 109-129 https://doi.org/10.1007/s10522-016-9667-3
- Xu D, Jiang Z, Sun Z et al (2019) Mitochondrial dysfunction and inhibition of myoblast differentiation in mice with high-fat-diet-induced pre-diabetes. J Cell Physiol 234, 7510-7523 https://doi.org/10.1002/jcp.27512
- Krol J, Loedige I and Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11, 597-610 https://doi.org/10.1038/nrg2843
- Saliminejad K, Khorram Khorshid HR, Soleymani Fard S and Ghaffari SH (2019) An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol 234, 5451-5465 https://doi.org/10.1002/jcp.27486
- Mok GF, Lozano-Velasco E and Münsterberg A (2017) microRNAs in skeletal muscle development. Semin Cell Dev Biol 72, 67-76 https://doi.org/10.1016/j.semcdb.2017.10.032
- Ji C and Guo X (2019) The clinical potential of circulating microRNAs in obesity. Nat Rev Endocrinol 15, 731-743 https://doi.org/10.1038/s41574-019-0260-0
- Ortiz-Dosal A, Rodil-Garcia P and Salazar-Olivo LA (2019) Circulating microRNAs in human obesity: a systematic review. Biomarkers 24, 499-509 https://doi.org/10.1080/1354750x.2019.1606279
- Kadrmas JL and Beckerle MC (2004) The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 5, 920-931 https://doi.org/10.1038/nrm1499
- Wei X and Zhang H (2020) Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression. Cancer Biol Med 17, 270-281 https://doi.org/10.20892/j.issn.2095-3941.2019.0420
- Windpassinger C, Schoser B, Straub V et al (2008) An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 82, 88-99 https://doi.org/10.1016/j.ajhg.2007.09.004
- Chen DH, Raskind WH, Parson WW et al (2010) A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations. J Neurol Sci 296, 22-29 https://doi.org/10.1016/j.jns.2010.06.017
- Gueneau L, Bertrand AT, Jais JP et al (2009) Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet 85, 338-353 https://doi.org/10.1016/j.ajhg.2009.07.015
- Cowling BS, McGrath MJ, Nguyen MA et al (2008) Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy. J Cell Biol 183, 1033-1048 https://doi.org/10.1083/jcb.200804077
- Lee JY, Chien IC, Lin WY et al (2012) Fhl1 as a downstream target of Wnt signaling to promote myogenesis of C2C12 cells. Mol Cell Biochem 365, 251-262 https://doi.org/10.1007/s11010-012-1266-2
- Domenighetti AA, Chu PH, Wu T et al (2014) Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice. Hum Mol Genet 23, 209-225 https://doi.org/10.1093/hmg/ddt412
- Ding J, Cong YF, Liu B, Miao J and Wang L (2018) Aberrant protein turn-over associated with myofibrillar disorganization in FHL1 knockout mice. Front Genet 9, 273 https://doi.org/10.3389/fgene.2018.00273
- Abreu P, Leal-Cardoso JH, Ceccatto VM and Hirabara SM (2017) Regulation of muscle plasticity and trophism by fatty acids: A short review. Rev Assoc Med Bras (1992) 63, 148-155 https://doi.org/10.1590/1806-9282.63.02.148
- Han S, Cui C, He H et al (2019) FHL1 regulates myoblast differentiation and autophagy through its interaction with LC3. J Cell Physiol 235, 4667-4678 https://doi.org/10.1002/jcp.29345
- Zhao Y, Chen M, Lian D et al (2019) Non-coding RNA regulates the myogenesis of skeletal muscle satellite cells, injury repair and diseases. Cells 8, 988 https://doi.org/10.3390/cells8090988
- Dambal S, Shah M, Mihelich B and Nonn L (2015) The microRNA-183 cluster: the family that plays together stays together. Nucleic Acids Res 43, 7173-7188 https://doi.org/10.1093/nar/gkv703
- Shao X, Wang M, Wei X et al (2016) Peroxisome proliferator-activated receptor-gamma: master regulator of adipogenesis and obesity. Curr Stem Cell Res Ther 11, 282-289 https://doi.org/10.2174/1574888X10666150528144905
- Lefterova MI, Zhang Y, Steger DJ et al (2008) PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 22, 2941-2952 https://doi.org/10.1101/gad.1709008
- John E, Wienecke-Baldacchino A, Liivrand M, Heinaniemi M, Carlberg C and Sinkkonen L (2012) Dataset integration identifies transcriptional regulation of microRNA genes by PPARgamma in differentiating mouse 3T3-L1 adipocytes. Nucleic Acids Res 40, 4446-4460 https://doi.org/10.1093/nar/gks025
- Yang WM, Min KH and Lee W (2016) MicroRNA expression analysis in the liver of high fat diet-induced obese mice. Data Brief 9, 1155-1159 https://doi.org/10.1016/j.dib.2016.11.081
- Zhao X, Jia Y, Chen H, Yao H and Guo W (2019) Plasma-derived exosomal miR-183 associates with protein kinase activity and may serve as a novel predictive biomarker of myocardial ischemic injury. Exp Ther Med 18, 179-187
- Feng Y, Hang W, Sang Z et al (2019) Identification of exosomal and nonexosomal microRNAs associated with the drug resistance of ovarian cancer. Mol Med Rep 19, 3376-3392